openPR Logo
Press release

2027 Companion Diagnostic Technologies Market Growth Trends and Rising Demand Analysis Led by Abbott, bioMerieux SA, Myriad Genetics, BioGenex, Thermo Fisher Scientific, Leica Biosystems Nussloch

05-24-2019 07:38 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

A companion diagnostic technologies are some of the tests which are performed to get an information of safety and effectives of corresponding drug or biological product. This test helps a doctor to determine whether a particular therapeutics products benefits the patient or having causes any side effects as well as it help to select patient treatment.

The global companion diagnostic technologies market is segmented on the basis of technology, Indication, end user and therapy. Based on technology, the market is segmented as PCR, IHC, NGS, and ISH. On the basis of Indication, the global companion diagnostic technologies market is segmented Breast cancer, NSCLC, colorectal cancer, neurological disorders, and infectious diseases. Based on the end user the market is classify into pharmaceutical & biopharmaceutical companies and reference lab.

Companion Diagnostic Technologies Market to 2027 - Global Analysis and Forecasts By Technology (PCR, IHC, NGS, ISH); Indication (Breast cancer, NSCLC, Colorectal Cancer, Neurological Disorders, Infectious Diseases); End User (Pharmaceutical and Biopharmaceutical Companies, Reference Lab) and Geography

Get Sample Report at https://www.theinsightpartners.com/sample/TIPRE00004732?sk

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global companion diagnostic technologies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Companion Diagnostic Technologies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The companion diagnostic technologies market is expected to grow during the forecast period owing to the key driving factors such as rising male geriatric population, awareness related to urological disorder and prostate cancer and others. In addition, various players in the emerging market have strong pipeline product and high potential which are anticipated to create several growth opportunities for the market during the forecast period.

The "Global Companion Diagnostic Technologies Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of companion diagnostic technologies with detailed market segmentation by technology, Indication, end user and geography. The global companion diagnostic technologies is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading the companion diagnostic technologies players and offers key trends and opportunities in the market.

Browse Complete Report at https://www.theinsightpartners.com/reports/companion-diagnostic-technologies-market?sk

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Companion Diagnostic Technologies Market - By Technology
1.3.2 Companion Diagnostic Technologies Market - By Indication
1.3.3 Companion Diagnostic Technologies Market - By End User
1.3.4 Companion Diagnostic Technologies Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. COMPANION DIAGNOSTIC TECHNOLOGIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. COMPANION DIAGNOSTIC TECHNOLOGIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

Buy this Research now at https://www.theinsightpartners.com/buy/TIPRE00004732?sk

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: https://www.theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2027 Companion Diagnostic Technologies Market Growth Trends and Rising Demand Analysis Led by Abbott, bioMerieux SA, Myriad Genetics, BioGenex, Thermo Fisher Scientific, Leica Biosystems Nussloch here

News-ID: 1751784 • Views:

More Releases from The Insight Partners

HR+/HER2- Breast Cancer Market Is Booming Worldwide | Latest Study Reveal for the forecast to 2031
HR+/HER2- Breast Cancer Market Is Booming Worldwide | Latest Study Reveal for th …
HR+/HER2- Breast Cancer Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market
Pharmaceutical Contract Development and Manufacturing Market Future Prediction Report By 2031
Pharmaceutical Contract Development and Manufacturing Market Future Prediction R …
Pharmaceutical Contract Development and Manufacturing Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon
Prenatal and Newborn Genetic Testing Market Future Prediction Report By 2031
Prenatal and Newborn Genetic Testing Market Future Prediction Report By 2031
Prenatal and Newborn Genetic Testing Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon
Patient Controlled Injectors Market Global Rising Demand & Huge Scope Till 2031
Patient Controlled Injectors Market Global Rising Demand & Huge Scope Till 2031
Patient Controlled Injectors Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market

All 5 Releases


More Releases for Companion

Companion Animal Drugs - Key Market Statistics
Companion animals are pets kept primarily for company, entertainment, and safety. Owners of companion animals consider them to be family, friends, and confidants. Dogs, cats, birds, rabbits, horses, goats, gerbils, rats, mice, and amphibians, others are considered as companion animals. Read Report Overview - https://www.transparencymarketresearch.com/companion-animal-specialty-drugs-market.html According to the American Society for the Prevention of Cruelty to Animals (ASPCA) defines companion animal to be domesticated or domestically-bred whose emotional, physical, social, and behavioral
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Companion Diagnostics Market - Easing of Regulatory Policies to Drive Global Dem …
Companion diagnostics include two types of tests namely tests which are developed along with target drugs and the other developed after the commercialization of drugs. Companion diagnostics combined with targeted therapeutics are being seen as a major breakthrough in the personalized medicine field. Companies operating in the companion diagnostics market are seeking an effective growth strategy in the development of this concept drug-diagnostic interaction as the healthcare sector is shifting
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.
Companion diagnostics Market: Companion diagnostic are used to determine patient …
The few companion diagnostics are already available in the market for specific types of cancer and many are already under clinical development. Companion diagnostics test depends on finding a specific biomarker in the patient and hence biomarker presence or absence determines whether or not the patient will respond to the treatment. This test require a biopsied tissue to access the expression of biomarker protein or mutant or aberrant genes. Companion